Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects
NCT03001115
·
clinicaltrials.gov ↗
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Hidradenitis Suppurativa (HS)
Sponsor
AbbVie